
News|Articles|September 29, 2026
PBM Satisfaction Stalls as Net Promoter Score Turns Negative
Author(s)Maggie L. Shaw
Fact checked by: Giuliana Grossi
The NPS index, ranging from –100 to +100, serves as a proxy for customers’ willingness to recommend products and services they themselves have used.
Advertisement
Advertisement
Employer and health plan satisfaction with pharmacy benefits managers (PBMs) has plateaued near its lowest point in a decade, while a separate loyalty measure shows a more striking change: Net Promoter Score (NPS) for PBMs has swung from +18 in 2022 to –13 in 2026. These findings come from the new Pharmacy Benefit Manager Customer Satisfaction Report published online today,1 which surveyed 250 benefits leaders about their willingness to recommend a product or service they themselves have used.2
Related to this article

Birth centers are unavailable in 10 states, and 39% of birth center births are self-pay, as licensing and Medicaid pay limit access, a report finds.

Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.

HR 1 brings Medicaid work requirements and narrower immigrant eligibility by January 2027, and CBO projects 10 million more uninsured by 2034.

CMS ends ACA subsidies for 189,000 enrollees with duplicate Medicare, Medicaid, or CHIP coverage or listed as deceased, with a 30-day dispute window.

An international eDelphi panel of 62 dermatologists agreed on a 2-step algorithm for tapering psoriasis biologics.

Real-world data from CHEST 2026 show ETI improved lung function and BMI in children with CF aged 6 to 11, with the most gains in F508del homozygotes.

Narcolepsy and idiopathic hypersomnia can go undiagnosed for years, and Epworth and RU-SATED screening help clinicians spot true sleepiness sooner.
Advertisement
Advertisement

